| Neri B, Molinara E, Pantaleo P, et al.
Weekly administration of docetaxel and epirubicin as first-line treatment for hormone-refractory prostate carcinoma. [Journal Article, Research Support, Non-U.S. Gov't]
Oncol Res 2009; 17(11-12):565-70.
Abstract | Full Citation | | Gadaleta C, Catino A, Ranieri G, et al.
Single-step Therapy -- Feasibility and Safety of Simultaneous Transarterial Chemoembolization and Radiofrequency Ablation for Hepatic Malignancies. [Journal Article]
In Vivo 2009 Sep-Oct; 23(5):813-20.
Abstract | Full Citation | Find Related Articles | | Birare N, Lwaleed BA, Cooper AJ
Multidrug resistance in a urothelial cancer cell line after 1-hour mitomycin C exposure. [Journal Article]
J Urol 2009 Nov; 182(5):2472-6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Jagt CT, Zuckermann M, Ten Kate F, et al.
Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis. [JOURNAL ARTICLE]
Pediatr Blood Cancer 2009 Aug 11.
Abstract | Full Citation | | Li Y, Zou D, Zhao Y, et al.
Clinical Characteristics and Treatment Outcome of Adult Acute Lymphoblastic Leukemia with t(4;11)(q21;q23) Using a Modified Hyper-CVAD Regimen. [JOURNAL ARTICLE]
Acta Haematol 2009 Aug 6; 122(1):23-26.
Full Citation | | Turan Y, Kocaaga Z, Karakoyun-Celik O, et al.
Osteoporosis in women with breast cancer and its effect on quality of life: a pilot study. [Journal Article]
J BUON 2009 Apr-Jun; 14(2):239-43.
Abstract | Full Citation | Find Related Articles | | Schmitt M, Sweep FC
Tissue inhibitor metalloproteinase type-1 (TIMP-1), a novel cancer biomarker predicting response of adjuvant anthracycline-based chemotherapy in patients afflicted with primary breast cancer. [JOURNAL ARTICLE]
Eur J Cancer 2009 Jul 31.
Full Citation | Find Related Articles | | Zhao L, Pan Y, Gang Y, et al.
Identification of GAS1 as an epirubicin resistance related gene in human gastric cancer cells with a partially randomized siRNA library. [JOURNAL ARTICLE]
J Biol Chem 2009 Jul 28.
Abstract | Full Citation | Find Related Articles | | Kim SJ, Taguchi T, Shimazu K, et al.
Good Response to Paclitaxel Predicts High Rates of Pathologic Complete Response for Breast Cancer Patients Treated Preoperatively with Paclitaxel Followed by 5-Fluorouracil, Epirubicin and Cyclophosphamide. [JOURNAL ARTICLE]
Oncology 2009 Jul 23; 77(2):134-139.
Abstract | Full Citation | | Warm M, Kates R, Thomas A, et al.
Side-effects of Pre-operative Epirubicin-Paclitaxel Therapy in Primary Breast Cancer Associated with Tumor Biology. [Journal Article]
Anticancer Res 2009 Jul; 29(7):2675-80.
Abstract | Full Citation |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
